KONJENİTAL KALP HASTALIĞI VE NÖROLOJİK ETKİLERİ

Yıl 2020, Cilt: 29 Sayı: 3, 163 - 172, 30.09.2020

Ferda Özlü , Perihan Eşsizoğlu , Hüseyin Şimşek , Sevcan Erdem

Öz

Neonatal konjenital
kalp hastalığı olan bebeklerin antenatal tanı alması, postnatal takip ve
cerrahi sonrası takipleri uzun dönem komplikasyon gelişmemesi açısından önemlidir.
Bu makalede konjenital kalp hastalıkları ve bunun nörolojik gelişim üzerine
etkileri özetlenmiştir.

Anahtar Kelimeler

Yenidoğan Bebekler, konjenital kalp hastalığı, Nörolojik Gelişim

Kaynakça

• Bernstein D. Congenital heart disease. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. (17th ed). Philadelphia: Saunders, 2004:1499-1502.
• Samânek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol 1992; 13:152-8.
• Karaaslan S, Başpınar O, Oran B, Baysal T, Elmacı AM, Yorulmaz A. Prevalence and distribution of children with congenital heart diseases in the central Anatolian region, Turkey. Turk J Pediatr 2004; 56:14-9.
• du Plessis AJ. Mcchanisms of brain injury during infant cardiac surgery. Semin Pediatr Neurol 1999; 6:32-47.
• Wernovsky G. Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease. Cardiol Young 2006; 16(1):92-104.
• Majnemer A. Benefits of early intervention in children with developmental disabilities. Semin Pediatr Neurol 1998; 5:62-9.
• Spittle AJ, Orton J, Doyle LW, Boyd R. Early developmental intervention programs post hospital discharge to prevent motor and cognitive impairments in preterm infants (review). Cochrane Database Syst Rev 2007; 24(11):54-95.
• Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation 2007; 115:800-812.
• Bernstein D. The cardiovascular system. n Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics, 17 th ed. Philedelphia, WB Saunders, 2004:1475-1598.
• Ferencz C, Rubin JD, McCarter RJ, Brenner JL, Neill CA, Perry LW. Congenital heart disease: prevalence at livebirth. The Baltimore- Washington Infant Study. Am J Epidemiol 1985; 121:31-36.
• Flanagan MF, Yeager SB, Weindling SN. Cardiac disease. In: Avery BG, Fletcher MA, MacDonald MG (eds). Neonatology Pathophysiology & Management of the Newborn (5th ed). Philadelphia: Lippincott, Williams&Wilkins, 1999:577-596.
• Balci MM, Akdemir R. NKX2.5 mutations and congenital heart disease: Is it a marker of cardiac anomalies? Int J Cardiol 2011; 17;147(3):44-5.
• Park MK. Congenital Heart Disease. In Park MK, eds. Pediatric cardiology for Practitioners. 5 th ed. St. Louis:Mosby, 2009:161-287.
• Saenz RB, Beebe DK, Trıplett LC. Caring for infants with congenital heart disease and their families. American Family Physician 1999; 59(7):1857-68.
• Keane JF, Lock JE, Fyler DC. Congenital Heart Disease. In John F Keane, eds. Nadas Pediatric Cardiology. 2nd Ed. Elsever Saunders 2007:525-773.
• Vick GW, Titus JL. Defects of the atrial septum including the atrioventricular canal. In: Garson A, Bricker JT, McNamara DG. The science and practice of pediatric cardiology. Pennsylvania: Lea&Febiger, 1990:1023- 54.